Orgenesis INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink

26 Mar 2026

ORGS

10-K: Orgenesis Faces Going Concern Doubt Amid Delisting, Losses

Orgenesis Inc. reports substantial doubt about its ability to continue as a going concern, with significant net losses and a worsening working capital deficit, following its delisting from Nasdaq.

OTC.Pink

15 Apr 2024

ORGS

Orgenesis INC

10-K: Orgenesis Inc. Reports Full Year 2023 Results, Navigates Financial Challenges

Orgenesis Inc. released its 2023 annual report, highlighting a significant decrease in revenue and ongoing financial uncertainties.